AI technology can only prove worthwhile for health care when it is input with good quality data, said Ron Williams, CEO of data analytics firm Business Evolution. “Data science has to be a part of the solution and not just an add-on or add-on,” he said. Roughly 70% of AI products fail because the focus is placed on the technology, rather than the data processes. AI works best in "standardised, stable environment", Bristol-Myers Squibb's Balazs Flink said, but the pharmaceuticals industry is not there yet.
AI technology can only prove worthwhile for health care when it is input with good quality data, said Ron Williams, CEO of data analytics firm Business Evolution. Speaking at the SCOPE summit, Williams stated that proper workflows should be the first step for companies using AI because poor processes lead to poor data, which in turn yields "disappointing results". Roughly 70% of AI products fail because the focus is placed on the technology, rather than the data processes. AI works best in "standardised, stable environment", Bristol-Myers Squibb's Balazs Flink said, but the pharmaceuticals industry is not there yet.